Aggiornamenti:
Latest update: July 2023
- New cases
- New panel appropriateness ratings
- Extra PinPoint cases added
- Guidelines updated: EAU 2023, NCCN v3.2023 on bladder cancer and NCCN v2.2023 on toxicities related to immunotherapy
- Guidelines added: ESMO-EONS-EANO 2020, ASCO 2020 on anticancer therapy-induced peripheral neurotoxicity
- Evidence updated
Update: December 2022
- Guidelines updated: EAU 2022, NCCN v2.2022 on bladder cancer and ESMO 2022, ASCO 2021, NCCN v1.2022 on toxicities related to immunotherapy
- Minor textual changes
Update: April 2021
- Guidelines added: NCCN v1.2021 on management of immunotherapy-related toxicities, ESMO on bladder cancer
- Guidelines updated: EAU 2021, NCCN v2.2021 on bladder cancer
- Evidence updated
July 2020
- Topic created
Ritorna all'argomento